{"title":"Effect of acute kidney injury care bundles on patient prognosis: a systematic review and meta-analysis.","authors":"Ying Huang, Lingling Guan, Chao Sun","doi":"10.1186/s12882-025-04349-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute kidney injury (AKI) is a severe complication among hospitalized patients. This study aimed to investigate the effect of care bundles on the prognosis of AKI patients.</p><p><strong>Methods: </strong>Electronic databases were searched from January 2012 to December 2023. Randomized controlled trials and cohort studies evaluating the effect of AKI care bundles were included. A meta-analysis using a random-effects model was conducted to explore the efficacy of the AKI care bundle.</p><p><strong>Results: </strong>A total of 12 studies with 30,152 participants were included. Based on the random-effects model, the AKI care bundles significantly improved the AKI severity (RR: 0.77, 95% CI: 0.60-0.98, I<sup>2</sup> = 64%) and the need for renal replacement therapy (RR: 0.66, 95% CI: 0.46-0.94, I<sup>2</sup> = 14%). However, our study did not find a statistically significant impact of AKI care bundle on the incidence of AKI incidence (RR: 0.95, 95% CI: 0.81-1.13, I<sup>2</sup> = 87%), major adverse kidney events (RR: 1.06, 95% CI: 0.65-1.73), in-hospital mortality (RR: 0.93, 95% CI: 0.81-1.07, I<sup>2</sup> = 19%), and length of hospital stay (MD: -0.16, 95% CI: -0.80, 0.47).</p><p><strong>Conclusion: </strong>This systematic review indicates that the implementation of the AKI bundle is a promising care model for AKI patients. There is a need for more high-quality prospective studies on AKI and patients at high risk of AKI to further determine feasible and standardized models of AKI bundle care.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9089,"journal":{"name":"BMC Nephrology","volume":"26 1","pages":"519"},"PeriodicalIF":2.4000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12465485/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12882-025-04349-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Acute kidney injury (AKI) is a severe complication among hospitalized patients. This study aimed to investigate the effect of care bundles on the prognosis of AKI patients.
Methods: Electronic databases were searched from January 2012 to December 2023. Randomized controlled trials and cohort studies evaluating the effect of AKI care bundles were included. A meta-analysis using a random-effects model was conducted to explore the efficacy of the AKI care bundle.
Results: A total of 12 studies with 30,152 participants were included. Based on the random-effects model, the AKI care bundles significantly improved the AKI severity (RR: 0.77, 95% CI: 0.60-0.98, I2 = 64%) and the need for renal replacement therapy (RR: 0.66, 95% CI: 0.46-0.94, I2 = 14%). However, our study did not find a statistically significant impact of AKI care bundle on the incidence of AKI incidence (RR: 0.95, 95% CI: 0.81-1.13, I2 = 87%), major adverse kidney events (RR: 1.06, 95% CI: 0.65-1.73), in-hospital mortality (RR: 0.93, 95% CI: 0.81-1.07, I2 = 19%), and length of hospital stay (MD: -0.16, 95% CI: -0.80, 0.47).
Conclusion: This systematic review indicates that the implementation of the AKI bundle is a promising care model for AKI patients. There is a need for more high-quality prospective studies on AKI and patients at high risk of AKI to further determine feasible and standardized models of AKI bundle care.
期刊介绍:
BMC Nephrology is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.